12:00 AM
 | 
Oct 08, 2007
 |  BioCentury  |  Emerging Company Profile

GenKyoTex S.A.

GenKyoTex S.A.

GenKyoTex S.A.
Geneva, Switzerland
Technology: Isoform-specific screening of NOX inhibitors
Disease focus: Cardiovascular,...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >